Skip to main content
. Author manuscript; available in PMC: 2022 Apr 20.
Published in final edited form as: Circulation. 2021 Mar 2:10.1161/CIRCULATIONAHA.120.050545. doi: 10.1161/CIRCULATIONAHA.120.050545

Table 3 -.

Hazard Ratios for CVD events by CAC score group

CAC Score CVD Event Type and All-cause Mortality, HR (95% CI)
All CVD Hard CVD All CHD Hard CHD All-cause mortality
CAC 0 as reference group
Model 1, unadjusted HRs
0 REF REF REF REF REF
1-399 3.31 (2.84 - 3.85) 3.00 (2.52 - 3.57) 4.18 (3.41 - 5.11) 3.70 (2.94 - 4.65) 2.41 (2.15 - 2.71)
400-999 6.88 (5.59 - 8.48) 5.68 (4.45 - 7.24) 9.76 (7.55 - 12.62) 7.69 (5.68 - 10.41) 4.23 (3.56 - 5.02)
≥ 1000 10.95 (8.76 - 13.68) 7.78 (5.92 - 10.21) 15.53 (11.83 - 20.37) 11.72 (8.48 - 16.21) 6.65 (5.53 - 7.99)
Model 2, fully adjusted * HRs
0 REF REF REF REF REF
1-399 2.06 (1.74 - 2.43) 1.80 (1.49 - 2.19) 2.77 (2.22 - 3.45) 2.24 (1.74 - 2.88) 1.20 (1.05 - 1.37)
400-999 3.12 (2.46 - 3.97) 2.51 (1.90 - 3.32) 4.92 (3.66 - 6.61) 3.42 (2.41 - 4.85) 1.48 (1.22 - 1.80)
≥ 1000 4.71 (3.63 - 6.11) 3.18 (2.31 - 4.36) 7.57 (5.50 - 10.42) 4.86 (3.32 - 7.11) 1.94 (1.57 - 2.41)
CAC 400-999 as reference group
Model 1, unadjusted HRs
400-999 REF REF REF REF REF
≥ 1000 1.57 (1.23 - 2.00) 1.36 (1.00 - 1.84) 1.57 (1.19 - 2.08) 1.51 (1.07 - 2.14) 1.57 (1.27 - 1.95)
Model 2, fully adjusted * HRs
400-999 REF REF REF REF REF
≥ 1000 1.65 (1.25 - 2.16) 1.33 (0.94 - 1.86) 1.66 (1.22 - 2.25) 1.51 (1.03 - 2.23) 1.34 (1.05 - 1.71)
*

Adjusted on age, sex, race/ethnicity, obesity, hypertension, total cholesterol, HDL-cholesterol, triglycerides, smoking, diabetes, family history of MI, anti-hypertensive medications, cholesterol medications